全文获取类型
收费全文 | 3632篇 |
免费 | 267篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 191篇 |
妇产科学 | 85篇 |
基础医学 | 473篇 |
口腔科学 | 91篇 |
临床医学 | 378篇 |
内科学 | 674篇 |
皮肤病学 | 51篇 |
神经病学 | 262篇 |
特种医学 | 392篇 |
外科学 | 418篇 |
综合类 | 112篇 |
一般理论 | 4篇 |
预防医学 | 356篇 |
眼科学 | 44篇 |
药学 | 222篇 |
1篇 | |
中国医学 | 6篇 |
肿瘤学 | 164篇 |
出版年
2023年 | 13篇 |
2022年 | 29篇 |
2021年 | 64篇 |
2020年 | 37篇 |
2019年 | 50篇 |
2018年 | 62篇 |
2017年 | 55篇 |
2016年 | 53篇 |
2015年 | 75篇 |
2014年 | 88篇 |
2013年 | 130篇 |
2012年 | 111篇 |
2011年 | 119篇 |
2010年 | 106篇 |
2009年 | 155篇 |
2008年 | 131篇 |
2007年 | 154篇 |
2006年 | 152篇 |
2005年 | 134篇 |
2004年 | 132篇 |
2003年 | 121篇 |
2002年 | 119篇 |
2001年 | 110篇 |
2000年 | 114篇 |
1999年 | 112篇 |
1998年 | 130篇 |
1997年 | 146篇 |
1996年 | 139篇 |
1995年 | 94篇 |
1994年 | 96篇 |
1993年 | 119篇 |
1992年 | 67篇 |
1991年 | 62篇 |
1990年 | 53篇 |
1989年 | 74篇 |
1988年 | 73篇 |
1987年 | 49篇 |
1986年 | 55篇 |
1985年 | 53篇 |
1984年 | 28篇 |
1983年 | 28篇 |
1982年 | 24篇 |
1981年 | 36篇 |
1980年 | 22篇 |
1979年 | 14篇 |
1978年 | 14篇 |
1977年 | 24篇 |
1976年 | 23篇 |
1975年 | 10篇 |
1970年 | 7篇 |
排序方式: 共有3929条查询结果,搜索用时 15 毫秒
71.
Cutaneous manifestations of malignancy are not uncommon, especially in advanced disease. They may also occur early in malignant disease or they may even signify recurrence particularly if they are paraneoplastic in nature. Clinical diagnosis can be difficult because of the wide spectrum of appearance of these lesions, and, in many cases, because of the lack of an identifiable underlying primary. Presented here is the case of a 65-year-old woman with multiple inflammatory cutaneous metastases, which were sclerodermoid in nature. These appeared 14 months after initial diagnosis of adenocarcinoma of unknown primary (ACUP) and signified the beginning of a rapid deterioration in her condition. The coexistence of limited systemic sclerosis (scleroderma) and ACUP initially raised several interesting diagnostic possibilities. Adenocarcinoma of unknown primary and the sclerodermoid reaction in malignancy are discussed. 相似文献
72.
73.
目的观察硫酸依替米星在老年肺部感染性疾病中应用的安全性。方法选择42例年龄大于60岁的老年肺部感染性疾病患者用硫酸依替米星治疗,观察临床疗效,记录用药前后血肝肾功能的变化及用药过程中的临床不良反应。结果依替米星治疗老年肺部感染的临床有效率为85.71%,不良反应的发生率9.52%。结论硫酸依替米星是一个毒性较低、安全有效的氨基糖苷类抗生素,可用于老年肺部感染性疾病。 相似文献
74.
R Drummond A Power A Evans K Luxford D Blakey G Delaney A Rodger 《Journal of Medical Imaging and Radiation Oncology》2005,49(1):44-52
In order to assess the impact on radiation oncology practice of the publication of evidence-based guidelines for technical aspects of therapeutic radiation for breast cancer, the Radiation Oncology Expert Advisory Group of the National Breast Cancer Centre conducted two postal surveys of radiation oncologists practising in Australia and New Zealand. Results from a survey conducted in 1998, prior to distribution of the guidelines, have been published previously. This article reports on results from a survey undertaken in 2002 and contains data from 102 respondents who manage women with breast cancer. The results show several important changes in practice since 1998, including increased use of CT scanning in breast cancer treatment planning and increased use of immobilization devices for patient treatment. There is also evidence of increased attention to technical aspects of treatment planning that reduce the potential risk of treatment toxicity. The influence of the guidelines, the wider availability of modern equipment and results from landmark clinical trials on change in radiation therapy practice is discussed. 相似文献
75.
76.
77.
BackgroundLeisure-time physical inactivity has a high prevalence and associated disease burden. Adult inactivity research ignores earlier life factors from which later life influences can originate. We aimed to establish whether early life factors influence adult inactivity.MethodsThe 1958 British Birth Cohort is a nationwide follow-up study of all births during 1 week in March, 1958. The outcome of the present study was leisure-time inactivity, defined as activity frequency of less than once a week, assessed at ages 33 years, 42 years, and 50 years (n=12 776). Early life factors (birth to 16 years) were categorised into three domains (physical, social, behavioural). We assessed stability of inactivity from 33 years to 50 years and associations with adult inactivity using logistic regression of: factors within domains, the three domains combined (ie, multivariable associations), and allowing for adult factors. Missing values were imputed with multiple imputation chained equations.FindingsAt each adult age, about 32% of participants were inactive (31% at 33 years, 34% at 42 years, and 30% at 50 years). 1189 (9%) were inactive at all three ages. In analysis of the three domains simultaneously, factors related to adult inactivity were: short prepubertal stature, poor hand control or physical coordination, and poor cognition (physical); low class at birth, minimal parental education, poor household amenities, parental divorce, and institutional care (social); and inactivity, average or lower sports aptitude, smoking, and externalising and unsociable behaviours (behavioural). Odds ratios for inactivity at age 33 years ranged from 0·86 per SD increase in cognition (95% CI 0·82–0·91) to 1·41 (1·23–1·61) for average or lower sports aptitude. Associations weakened slightly but were mostly maintained after adjustment for adult covariates. After allowing for adult covariates participants with unskilled manual backgrounds had 23% higher odds of inactivity at 50 years than those from professional or managerial backgrounds.InterpretationOur study, based on self-report, focuses only on leisure-time inactivity. However, to have repeat, prospective data on inactivity spanning several decades in adulthood is rare, and leisure-time inactivity is likely to be amenable to modification. Adult inactivity is only moderately stable, providing opportunities for behaviour change. Factors from early life are associated with adult inactivity, allowing for early identification of groups vulnerable to later inactivity.FundingThis work was supported by the Department of Health Policy Research Programme through the Public Health Research Consortium. The Great Ormond Street and University College London Institute of Child Health was supported in part by the Department of Health's National Institute for Health Biomedical Research Centre. 相似文献
78.
S.W. Considine N.F. Davis L.C. McLoughlin P. Mohan J.C. Forde R. Power G. Smyth D.M. Little 《The surgeon》2019,17(1):1-5
Introduction
Transplant units are exploring strategies to increase the availability of donor kidneys. The use of en-bloc kidney transplantation (EBKT) from paediatric donors represents one potential solution. We present our long-term experience with paediatric EBKT among adult recipients.Methods
Twenty-three paediatric to adult EBKTs were performed by the Irish National Kidney Transplant Service between 1990 and 2016. The primary outcome variable was long-term en-bloc allograft survival rate. Secondary outcome variables were incidence of allograft thrombosis, incidence of delayed graft function, overall patient survival and serum creatinine at most recent follow-up. Outcomes were compared to single kidney transplant recipients from the same time period.Results
Mean donor age was 1.8 ± 0.97 years (range: 7 months to 3 years). Recipient age was 46 ± 12 years. Mean follow-up was 133 ± 64 months (range: 36–264). Overall graft survival was 100%, 91% and 80% after 1, 5 and 10 years respectively, compared to 92%, 79% and 61% in single kidney transplant recipients (p = 0.04). There were 5 cases of allograft failure, 3 due to death from unrelated causes. Median time to graft failure was 108 months (range: 36–172). Mean serum creatinine was 72.6 ± 21.6 μmol/l after the follow-up period. There were no cases of graft thrombosis or delayed graft function. Overall survival was 96.4%, 88.0%, 76.23% and 50.5% at 1, 5, 10 and 20 years respectively.Conclusion
En-bloc paediatric kidney transplantation is associated with excellent long-term allograft and patient survival and is a feasible strategy for increasing the transplant donor pool in carefully selected recipients. 相似文献79.
80.
The use of targeted/biologic therapies is now commonplace in the treatment of malignant and non-malignant diseases. The novel
mode of action of these drugs has resulted in unpredictable and in some cases unexpected side effects. Given the widespread
use of bevacizumab and its distinct mode of action, it is important that oncologists report any unexpected adverse events
that may be associated with the drug. Herein, we report three cases of spontaneous nasal septum perforation secondary to bevacizumab.
We hypothesize an etiology for this rare event and reasons why it is reasonable to rechallenge the patient. 相似文献